Return to PJ Online Home Page
The Pharmaceutical Journal Vol 265 No 7107 p169
July 29, 2000 Continuing education

The College of Pharmacy Practice Credit for Learning: 2

Childhood diseases

Set out below is a series of multiple choice questions designed to test your understanding of the three articles in our series on childhood diseases (Gastrointestinal problems [July 8, p52], infections [July 15, p91] and skin problems [this week, p164]). All pharmacists are invited to complete the questions and send their answers, together with a stamped and addressed A5 (230 x 160mm) envelope, to: The College of Pharmacy Practice, Barclays Venture Centre, University of Warwick Science Park, Coventry CV4 7EZ, by August 21.
Results will be returned along with a certificate of completion which, for college members, will count towards continuing education requirements. The correct answers will be published in The Journal.
A provisional time of four hours is given for the articles relating to this Credit for Learning exercise.
Genus Pharmaceuticals will provide a £500 prize to the pharmacist who achieves the highest marks overall in the four Credit for Learning exercises published in 2000. There will be a runner up prize of £200.
Completion of Credit for Learning questions entitles pharmacy undergraduates to one point towards the professional development certificate, a joint initiative between the BPSA and the College of Pharmacy Practice.
While we will correct obvious errors, The Journal does not have the resources to enter into correspondence about answers to questions.
This web page is for information only. Answers should be submitted on the printed form.

The questions

Draw a ring around either T or F (T=true, F=false). There may be more than one true answer to each question.

1. In infant feeding: 
(a) Posseting is the repeated regurgitation of milk into the mouth after feedingT/F
(b) Posseting is normally regarded as a risk factor in the onset of gastro-oesophageal reflux disease T/F
(c) A bottle fed infant of 4kg will require around 600ml of formula feed per day T/F
(d) Posseting usually resolves during the first six months of life T/F
(e) Enfamil AR has a lower sodium content than Infant Gaviscon T/F
2. In gastro-oesophageal reflux in infants: 
(a) There is a failure to gain weight T/F
(b) Projectile vomiting occurs T/F
(c) Pain/distress is experienced on eating T/F
(d) Mothers are advised to put their baby in a prone sleeping position T/F
(e) Treatment might include an H2 antagonist T/F
3. Regarding colic and related problems: 
(a) Colic is much more common in bottle-fed babies than in breast-fed babies T/F
(b) Controlled trials have shown dimeticone to be ineffective in relief of colic T/F
(c) Dicyclomine has been associated with seizures in infants T/F
(d) There is evidence that intolerance to cow's milk may produce colic in some infants T/F
(e) There is little evidence to suggest gripe water is effective against trapped wind T/F
4. In relation to diarrhoea in infants: 
(a) Most acute cases are bacterial or protozoal in aetiology T/F
(b) It may be a presenting symptom of meningitis T/F
(c) Loperamide is often useful in more severe cases T/F
(d) In fluid replacement, glucose enhances sodium uptake in the small intestine T/F
(e) Hypertonic soft drinks are a useful alternative to glucose and electrolyte solution if the latter is unavailable T/F
5. In the treatment of childhood infections: 
(a) A child who contracts an acute viral infection every four to six weeks should be referred for assessment of their immune status T/F
(b) The first dose of oral polio vaccine is normally administered at two months of age T/F
(c) MMR is normally administered between four and 12 months T/F
(d) MCCV is administered between two and four months T/F
(e) BCG is given routinely to children in the UK T/F
6. In chickenpox in children: 
(a) There is an incubation period of between 10 and 21 days before spots appear T/F
(b) A child is infectious throughout the incubation period T/F
(c) It may be fatal in the newborn T/F
(d) The fever usually precedes the rash by three or four days T/F
(e) The rash occurs more on the head and trunk than on the limbs T/F
7. In childhood infections: 
(a) A measles rash typically lasts three days T/F
(b) Erythema infectiosum in pregnant women carries no risk to the foetus T/F
(c) Scarlet fever is caused by Staphylococcus epidermidis T/F
(d) Meningococcal disease is characterised by a rash which does not blanch on pressure from a glass T/F
(e) Kawasaki disease may result in coronary artery aneurysm T/F
8. In respiratory infections in childhood: 
(a) Croup is normally associated with an underlying bacterial infection T/F
(b) Broad spectrum antibiotics should be avoided in lower respiratory tract infections T/F
(c) Most children with viral bronchiolitis will require ribavirin therapy T/F
(d) Most infants with asthma do not require antibiotic treatment during acute episodes T/F
(e) Pertussis infection, once established, is unlikely to respond to antibiotic treatment T/F
9. In relation to skin conditions in childhood: 
(a) Two thirds of common warts resolve spontaneously within two years T/F
(b) Cryotherapy is regarded as the most effective treatment of common warts T/F
(c) Impetigo is generally caused by Staphylococcus aureus infection T/F
(d) Children with Tinea corporis should be excluded from school until treatment is completed T/F
(e) Tinea capitis may be contracted from pets T/F
10. In treating childhood skin conditions: 
(a) Benzyl benzoate 25 per cent is a suitable treatment for scabies T/F
(b) Topical corticosteroids for atopic eczema must continue to be applied to an affected area for at least five days after inflammation has settled T/F
(c) A five-year-old child is likely to need a prescription for between 550 and 600g of corticosteroid cream to allow twice daily application from head to toe for one month T/F
(d) Secondary infection with Staphylococcus aureus in atopic eczema may require antibacterial treatment T/F
(e) Greasy emollients are generally more effective than lighter emollients in childhood eczema T/F

The College of Pharmacy Practice Credit for Learning: 2